Original language | English |
---|---|
Pages (from-to) | 21-23 |
Number of pages | 3 |
Journal | JAMA Dermatology |
Volume | 159 |
Issue number | 1 |
DOIs |
|
Publication status | Published - 18 Jan 2023 |
Externally published | Yes |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: JAMA Dermatology, Vol. 159, No. 1, 18.01.2023, p. 21-23.
Research output: Contribution to journal › Comment/debate
TY - JOUR
T1 - COP27 Climate Change Conference - Urgent Action Needed for Africa and the World
AU - Atwoli, Lukoye
AU - Erhabor, Gregory E.
AU - Gbakima, Aiah A.
AU - Haileamlak, Abraham
AU - Ntumba, Jean Marie Kayembe
AU - Kigera, James
AU - Laybourn-Langton, Laurie
AU - Mash, Bob
AU - Muhia, Joy
AU - Mulaudzi, Fhumulani Mavis
AU - Ofori-Adjei, David
AU - Okonofua, Friday
AU - Rashidian, Arash
AU - El-Adawy, Maha
AU - Sidibé, Siaka
AU - Snouber, Abdelmadjid
AU - Tumwine, James
AU - Yassien, Mohammad Sahar
AU - Yonga, Paul
AU - Zakhama, Lilia
AU - Zielinski, Chris
N1 - Funding Information: Conflict of Interest Disclosures: Chris Zielinski receives consulting fees from the UK Health Alliance on Climate Change. Paul Yonga receives honoraria from Novartis, bioMerieux, and Pfizer, advisory board fees from Pfizer, and fees for serving on a DSMB from the US National Heart, Lung, and Blood Institute all unrelated to the topic of this Editorial. James Kigera is the ex-officio president and secretary of the Kenya Orthopedic Association. Bob Mash reports receiving a grant on climate change and primary health care with University Ghent, funded by VLIR (Flemish Interuniversity Network). Joy Muhia is an unpaid board member of the International Working Group for Health systems strengthening unrelated to the topic of this Editorial. David Ofori-Adjei receives advisory board fees from Inovio Pharmaceuticals and is a member of the board of directors of GLICO Healthcare, all unrelated to the topic of this Editorial. No other disclosures were reported.
PY - 2023/1/18
Y1 - 2023/1/18
UR - http://www.scopus.com/inward/record.url?scp=85146532237&partnerID=8YFLogxK
U2 - 10.1001/jamadermatol.2022.5429
DO - 10.1001/jamadermatol.2022.5429
M3 - Comment/debate
C2 - 36383453
AN - SCOPUS:85146532237
SN - 2168-6068
VL - 159
SP - 21
EP - 23
JO - JAMA Dermatology
JF - JAMA Dermatology
IS - 1
ER -